#65 About the GFR formulas – How to measure renal function in 2026? with Pierre Delanaye
A pinch of salt - A podcast by ERAShow Notes
In this episode of A pinch of salt, we welcome Pierre Delanaye for a forward-looking discussion on how we should assess kidney function in 2026. Together, we explore the strengths and limits of today’s GFR equations (MDRD, CKD-EPI, cystatin C-based approaches), the promise of emerging biomarkers and AI-driven tools, and the crucial question of fairness and accuracy across diverse populations.
More from A pinch of salt - A podcast by ERA
For decades, “volume status” meant a (un)healthy dose of educated guessing. What if you could just look? Faeq Husain-Syed (Giessen) joins "A pinch of salt" to explain how kidney venous Doppler makes congestion visible, and whether Point-of-care Ultrasound is ready for prime time.
Heart over there, kidney over here, metabolism somebody else’s problem? Not anymore. Amaryllis Van Craenenbroeck (KU Leuven) makes the case for Cardiovascular-Kidney-Metabolic syndrome as one continuum, not three separated clinics. Four drug classes, three organs, one patient, prevention upstream, and a fair hearing for the sceptics who call it disease-mongering.
We watch creatinine rise and fall all the time, but a failing kidney allograft is more than a numbers game. Annelies de Weerd (Erasmus MC Rotterdam) covers when to call it failure, the immunosuppression taper, and helping patients through what feels like a step backwards.
Every nephrology trainee in Europe has heard about it, stressed about it, or is quietly pretending it doesn’t exist: the ESENeph. Is it a genuine European passport, or just one more exam? Hugo Diniz talks to David Lappin, about the exam’s format, its career value, and why trainees should sign up.